Canada markets closed

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
7.16-0.13 (-1.78%)
At close: 04:00PM EDT
6.85 -0.31 (-4.33%)
After hours: 07:45PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,290
60
249
4,838
Cost of Revenue
0
0
199
472
Gross Profit
1,290
60
50
4,366
Operating Expenses
Research Development
4,291
4,758
5,692
5,916
Selling General and Administrative
6,393
6,034
4,989
5,801
Total Operating Expenses
11,403
10,295
9,404
11,717
Operating Income or Loss
-10,113
-10,235
-9,354
-7,351
Interest Expense
-
-
-
769
Total Other Income/Expenses Net
-96
-24
577
713
Income Before Tax
-10,180
-10,206
-8,776
-7,407
Income from Continuing Operations
-10,180
-10,206
-8,776
-7,407
Net Income
-10,180
-10,206
-8,776
-18,242
Net Income available to common shareholders
-10,180
-10,206
-8,776
-18,242
Basic EPS
-8.20
-15.20
-18.00
-96.60
Diluted EPS
-8.20
-15.20
-18.00
-96.60
Basic Average Shares
746.138
671.7
486.5
188.65
Diluted Average Shares
746.138
671.7
486.5
188.65